Institute of Nuclear Medicine and Allied Sciences, New Delhi, India.
School of Basic and Applied Science, Galgotias University, Greater Noida, Uttar Pradesh, India.
Drug Dev Ind Pharm. 2020 Jun;46(6):878-888. doi: 10.1080/03639045.2020.1762200. Epub 2020 May 13.
Nanoparticles have emerged as an important carrier system to treat wounds as they permit the topical administration of an antimicrobial drug in a sustained and effective manner. On the other hand, if active excipients are added during the formulation, such as chitosan or graphene oxide, the developed Nano formulation could significantly improve its potential for chronic wound healing. Given that, we have conceived the fabrication and evaluation of rosmarinic acid loaded chitosan encapsulated graphene nanoparticles (RA-CH-G-NPOs) formulation to enhance wound healing capacity. The prepared nanoparticles were characterized by particle size, Zeta potential, FT-IR, SEM, TEM and AFM. It was observed the average diameter of RA-CH-G-NPOS is around 417.5 ± 18.3 nm and showed sustained release behavior. Optimized RA-CH-G-NPOs were incorporated into Carbopol gel and evaluated for drug content, pH, release, texture analysis, and viscosity. The antibacterial activity of optimized formulation was examined as a minimum inhibitory concentration against . The fabricated RA-CH-G-NPOs were than evaluated for antimicrobial activity by microdilution assay The combination of RA, Chitosan and Graphene oxide (GO) showed higher antibacterial activity of 0.0038 ± 0.2 mg/mL. Further, these nanoparticles were evaluated in- vivo for wound healing efficacy in rats. Histopathological evaluations demonstrated that RA-CH-G-NPOs showed significantly enhanced wound contraction, enhanced cell adhesion, epithelial migration, and high hydroxyproline content leading to faster and more efficient collagen synthesis as compared to plain carbopol, plain RA and controls. Hence the topical administration of fabricated RA-CH-G-NPOs appears to be an interesting and suitable strategy for the treatment of chronic wounds.
纳米粒子已成为治疗伤口的重要载体系统,因为它们可以以持续有效的方式局部施用抗菌药物。另一方面,如果在制剂中添加活性赋形剂,如壳聚糖或氧化石墨烯,所开发的纳米制剂可显著提高其用于慢性伤口愈合的潜力。考虑到这一点,我们构思了载有迷迭香酸的壳聚糖包封的氧化石墨烯纳米粒子(RA-CH-G-NPOs)制剂的制备和评估,以增强伤口愈合能力。所制备的纳米粒子通过粒径、Zeta 电位、FT-IR、SEM、TEM 和 AFM 进行了表征。观察到 RA-CH-G-NPOS 的平均直径约为 417.5 ± 18.3nm,并表现出持续释放行为。将优化的 RA-CH-G-NPOs 掺入 Carbopol 凝胶中,并对其药物含量、pH 值、释放、质地分析和粘度进行评估。优化制剂的抗菌活性作为对 的最小抑菌浓度进行了检查。然后通过微量稀释法评估了所制备的 RA-CH-G-NPOs 的抗菌活性。迷迭香酸、壳聚糖和氧化石墨烯(GO)的组合显示出更高的抗菌活性,为 0.0038 ± 0.2mg/mL。此外,这些纳米粒子在大鼠体内进行了伤口愈合功效的评估。组织病理学评估表明,与普通 Carbopol、普通 RA 和对照相比,RA-CH-G-NPOs 显示出明显增强的伤口收缩、增强的细胞粘附、上皮迁移和高羟脯氨酸含量,从而更快、更有效地合成胶原蛋白。因此,局部给予制备的 RA-CH-G-NPOs 似乎是治疗慢性伤口的一种有趣且合适的策略。